April Christensen points out the value of clinical trials for patients as well as medical practices.
April Christensen points out the significance of finding the right practice manager organization and the resources they have to offer.
April Christensen speaks to how practice managers need to adjust to the ever-changing oncology market.
Randomized Phase 3, Multicenter, Open-Label Study Comparing Evofosfamide (EVO) in Combination with Doxorubicin (D) versus D Alone in Patients with Advanced Soft-Tissue Sarcoma (STS): Study TH-CR-406/SARC021
This randomized phase 3 study compared the efficacy and safety of evofosfamide (EVO) plus doxorubicin (D) with D alone in patients with locally advanced unresectable or metastatic STS previously untreated with chemotherapy for advanced disease. Patients on EVO+D could receive [ Read More ]